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Acute Myocardial Infarction:
Does the Lack of Q Waves Help
Or Hinder?*
JACK FERLINZ, MD, FACC
Southfield and Detroit, Michigan
Pathophysiologic spectrum of acute myocardial ischemic
syndromes. Recent studies have shown quite convincingly
that various acute myocardial ischemic syndromes may be
thought of as representing different stages of an evolving
pathophysiologic spectrum. Thus, we now have rather per-
suasive evidence that unstable angina, non-Q wave and Q
wave myocardial infarction have underlying similarities link-
ing them (1,2). The continuum of the acute ischemic spec-
trum would then be such that unstable angina would be
characterized by short spans of severe ischemia, but no (or
only very limited focal) myocardial necrosis; when the
pathophysiologic processes causing ischemia reduce the
coronary blood flow for periods of 20 min to 2 h, a non-Q
wave infarct would develop, and as this critical reduction of
coronary blood flow is maintained for >2 h, a Q wave
myocardial infarction would generally occur (3,4).
That the clear-cut transition between these different
stages may not always be readily apparent is evident on brief
examination of the complexities of the pathophysiologic
processes involved. Although it is generally accepted that
even the very accurate, specific and sensitive radioimmuno-
assay for creatine kinase isoenzyme MB (MB CK) survey
fails to detect this marker in patients with only angina (5), it
has been shown in experimental animals that MB CK may be
released into coronary blood flow by transient. severe isch-
emia without associated cellular myocardial necrosis (6).
Mild increases in MB CK have also been detected in 20% of
patients within 24 h after successful percutaneous translu-
minal coronary angioplasty (7). It is probable, therefore, that
some variants of unstable angina may be characterized by
small areas of microinfarction with early washout of MB
CK-representing yet another link to a non-Q wave myocar-
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dial infarction (which, as has been consistently shown, is
associated with lower average total CK values than seen in Q
wave infarction [8] and shorter time intervals to peak CK
[9]). Nevertheless, our grasp of precise relations among the
respective acute ischemic syndromes is far from complete.
As we gain a better understanding and formulate new
concepts, many early theories are further modified. For
example, Spodick, who was among the first to suggest that
the terms "transmural" and "nontransmural" should be
eliminated (and replaced by "Q wave" and "ST") when
referring to the electrocardiographic (ECG) patterns of an
acute myocardial infarction (10), now finds that "the 'Q'
versus 'non-Q' dichotomy is inadequate for clinicopatho-
logic and prognostic ECG classification of acute myocardial
infarction" (11).
The present study. In this issue of the Journal, the
Multicenter Diltiazem Post-Infarction Trial (MDPIT) Re-
search Group (12) attempts to assess once again the progno-
sis associated with two types of initial (first) acute myocar-
dial injury: Q wave versus non-Q wave myocardial
infarction. Their conclusions markedly differ from what we
thought we knew about the presage of a given infarct type
and its location. In their study (12), the cardiac death rate
was not significantly different for patients with Q wave
myocardial infarction than for patients with a non-Q wave
infarction; this was the observed outcome not only at the end
of I year after an acute heart attack, but also during the total
follow-up period of up to 52 months. More surprisingly, the
reinfarction rate was almost identical for the Q wave and
non-Q wave groups. Furthermore, the subset of patients
with an anterior Q wave myocardial infarction had a rein-
farction rate that was substantially higher than that seen in
the inferoposterior Q wave subset-and even slightly higher
than that noted for the entire non-Q wave group. Finally, the
cardiac death rate was almost identical among the patients
with anterior and in those with inferior Q wave myocardial
infarction. Therefore. one must conclude with the authors
that in this MDPIT study (12) neither the infarct type (Q
wave versus non-Q wave) nor Q wave location (anterior
versus inferoposterior) independently contributed to cardiac
mortality before or after adjustments for what the authors
believed to be the pertinent baseline clinical covariates.
Discrepancies with previous findings. Setting aside for a
moment the present study, what have we learned to be the
distinguishing features of various acute myocardial ischemic
syndromes? It has been shown that the short-term mortality
in patients with a non-Q wave infarct is only about one half
of that seen in patients with a Q wave infarct (13,14). This
finding correlates well with the aforementioned lower aver-
age total CK values (8) and the initially better preserved left
ventricular function and smaller infarct size in patients with
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a non-Q wave myocardial injury (15,16). In contrast to the
rather favorable early outcome for the non-Q wave group,
the late reinfarction rate has been shown to be much higher
in patients with a non-Q wave (as opposed to a Q wave)
myocardial infarction (9,17). Such adverse evolution is pre-
sumably related to the presence of still viable myocardium
with only marginal blood supply. These unstable conditions
quickly lead to deterioration of the precarious oxygen sup-
ply/demand ratio, often producing a new unstable angina in
patients who experienced a non-Q wave myocardial infarc-
tion within the preceding year (18). It has been postulated
that more harmful functional consequences frequently fol-
low a new acute occlusion of a formerly mild coronary
stenosis than follow an acute occlusion of an already severe
stenosis (19). Thus, a tight but still patent coronary artery
lesion (and the ischemia that it engenders) can exert a
protective effect (greatly aided by coronary collateral ves-
sels), but this scenario, frequently seen within hours after an
acute non-Q wave myocardial infarction, is then followed by
a clear-cut trend in progression from subtotal to total coro-
nary occlusion (20). Finally, we know from numerous stud-
ies that patients with anterior myocardial infarction have a
higher mortality rate; when corrected for infarct size, the
extent of impairment of left ventricular function caused by
inferior wall infarction is about one half of that produced by
anterior wall infarction (21,22). These accumulated data
favoring the prognosis of inferior infarct over the anterior
variety are seen not only in the Q wave, but also extend to
the non-Q wave heart attacks (23). Indeed, patients with
inferior myocardial infarction have a prognosis that is gen-
erally so good that even the issue of thrombolytic therapy
remains unsettled (24).
In view of this very persuasive amassed evidence, why
are we now told (12) that our understanding of acute myo-
cardial ischemic syndromes might have been incomplete or
at times perhaps actually suspect? A number of possibilities
may explain at least some of the differences between the
present study as opposed to the general consensus in the
medical literature. It is possible that these MDPIT patients-
for reasons that may not be readily apparent-happen to be
quite different from the patients in earlier research protocols
and thus have a different clinical outcome. Alternatively,
many of the discrepancies may be a direct result of the
preselected patient group examined in this study. Patients in
this study were enrolled for up to 15 days after the onset of
an acute myocardial infarction; subjects with high early
mortality (perhaps those with an anterior Q wave infarction)
were therefore excluded. Furthermore, beyond this "remov-
al" from the study of the highest risk patients by early
mortality, a number of subjects also received prior treatment
with various drugs (including aspirin) or were subjected to
coronary angioplasty or bypass grafting (these interventions
may also account for some of the observed differences).
Finally, the majority of patients in the subset with anterior Q
wave infarction had a left ventricular ejection fraction
<40%, whereas only a distinct minority of patients with
inferoposterior Qwave or non-Q wave myocardial infarction
exhibited similarly depressed left ventricular function. Left
ventricular ejection fraction remains one of the best inde-
pendent predictors of mortality during prolonged follow-up
(25), yet this study (12) failed to demonstrate an increased
mortality rate for anterior Q wave infarction; one must,
therefore, fear that the statistically insignificant differences
in mortality among the acute ischemic syndromes are erro-
neous (resulting from a type II or beta error of hypothesis
testing).
Identifying the high risk patients with acute myocardial
ischemic syndromes. Regardless of the reasons for these
discrepancies, Q wave and non-Q wave myocardial infarcts
can now be precisely delineated (26) and their rather fre-
quent extensions into the right ventricle precisely docu-
mented (27). Therefore, it is very important to identify the
subsets of patients with non-Q wave myocardial infarction
that are at greatest risk for future adverse events; it has
already been shown that a non-Q wave heart attack in
patients with left ventricular hypertrophy (28) or a low peak
CK level (29) carries a grim prognosis. In addition, the
Diltiazem Reinfarction Study Research Group recently pub-
lished a report (30) on >500 patients with acute non-Q wave
myocardial infarction, showing that in the subset of subjects
with persistent ST segment depression, ST elevation at
discharge and a history of congestive heart failure, the
age-adjusted risk for mortality was 14 times as high as for
patients without these pathophysiologic features. Most re-
cently, we have had a chance to examine perhaps the most
intriguing study in this investigational area: when patients
with an acute myocardial infarction were labeled with both
indium-Ill-labeled antimyosin monoclonal antibody (which
binds with human myosin irreversibly damaged by an ische-
mic event) and thallium-201 and then studied with two sets of
single photon emission computed tomography (SPECT)
scintigrams obtained simultaneously, the mismatched or
overlapping images identified the subsets of patients that
went on to have further ischemic events (31). Of particular
interest was the fact that the overlapping thallium and
antimyosin images were predominantly seen in patients with
non-Q wave infarcts and that a high percentage of this group
had further adverse cardiovascular incidents.
Who should have aggressive therapy? One wonders
whether many patients in the present study with non-Q wave
myocardial infarction shared some of the features that
placed them in a high risk category (thus their "parity" with
the Q wave group). The answer to this question carries great
clinical significance; for patients who are identified as at high
risk for reinfarction or death, aggressive therapy is manda-
tory. We know from the Worcester Heart Attack Study (32)
that the in-hospital mortality rate is 6.2% for Q wave and
only 0.9% for non-Q wave myocardial infarction in patients
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aged <55 years. It is now obvious, however, that such
patients have a significant increase in the frequency of
jeopardized myocardium when compared with patients with
Q wave infarctions (33); a recent survey of 14 studies
examining the consequences of such a jeopardized myocar-
dium has shown that among 4,095 patients with a Q wave
infarction, the aggregate incidence of reinfarction was 5.7%
as opposed to an almost 3 times higher incidence of 15.7%
among 1,201 patients with a non-Q wave myocardial infarc-
tion (34). In such patients at high risk, aggressive interven-
tions, especially in evolving myocardial infarction, are man-
datory if we are to lower morbidity and mortality (35). The
Western Washington Intracoronary Streptokinase Trial (36)
has shown that preservation of the "twilight zone" of
ischemic myocardium is of crucial importance: left ventric-
ular ejection fraction determined within the first few hours of
an acute myocardial infarction was the most important
baseline predictor of survival at I year. Because of the dire
consequences of compromised left ventricular function in
acute ischemic syndromes, thrombolytic therapy has been
even attempted in patients with only unstable angina (37)
(coronary angioplasty combined with thrombolysis took this
aggressive management of unstable angina yet a step further
[38]). It is still unclear whether such aggressive interventions
are indicated for most people with uneventful non-Q wave
myocardial infarction, much less for patients with unstable
angina. However, it is obvious that patients with an acute
myocardial infarction-especially of the non-Q wave varie-
ty-who are identified to be at a high risk for subsequent
adverse (often fatal) cardiac events must be managed with all
the tools at our disposal; without appropriate interventions,
deleterious sequelae are almost inevitable. Therefore, the
time has come not only to form a consensus concerning the
most likely clinical outcome after the onset of various acute
ischemic syndromes, but also to define the sequential steps
in screening with noninvasive and invasive approaches ca-
pable of letting us know which prognostic indicators demand
an aggressive intervention and which allow us to treat our
patients more conservatively.
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